Europe – Effective Protection Period for Medicines has Declined in Last Decade, EC Report Finds

The European Commission (EC) on Thursday released a report detailing how patents and various exclusivity periods are used to protect pharmaceuticals from generic and biosimilar competition in the EU.

The report establishes a new term, known as the “effective protection period,” which is the “period where the medicinal product enjoys protection from primarily generic competition in any of the EU countries.”…